. >>> and british pharmaceutical giant smith klein approaching companies on better brands, gsk has aboutrugs in what it calls its established portfolio including heart burn drugs like zantac, with tough competition from generic rivals, they are looking to focus on lucrative new drugs. >>> big pharmaceutical companies along with wall street investors are gearing up for one of the biggest events in the industry. this weekend's annual meeting of the american society of clinical oncology, getting under way in chicago. >> reporter: asco is bound to move stocks, analysts say the key thing will be drugs fighting cancer, how do they work? immunotherapies work in different ways, some harvest the cells, multiplying them, and reinventing into the body to fight the cancer. another drug recodes the cells to be better cancer hunters, then destroys them and finds other cancers. others are medications taken by infusion. some pack a hearty punch against cancer cells, others help immune cell cells see the enemy, revealing invisible cancer cells so the immune cells can identify the target and then attack.

police there say that they uncovered widespread bribery at glak goe smith klein's china unit.glaxo's chinese drug prices in order to cover the cost of bribes passed on to doctors, hospitals and medical associations. >> translator: in order to aclooef the high sales targets set by glaxosmithkline headquarters, they set up and expended a number of sales departments with the support of a few criminal suspects. they put the sales cost into the price of medicine. using profits from overinflated drug prices, these departments bribed hospitals, doctors and medical institutions, earning illegal profits of billions of yuan. the more drugs they sold, the more bribes they gave. the more bribing they gave, higher the drug price was. to accomplish sales targets, they adopted many new methods to boost the sales. they encouraged their employees to bribe on a large scale. glaxosmithkline's behavior demonstrates a complete chain of bribery. >> reporter: investigators say they've now wrapped up their case. and they passed it on to the chinese courts. we'll now be watching to see who will be fac

that's back in sew smith klein's -- glaxosmithkline's company.u start tomorrow? yes sir. alright. let's share the news tomorrow. today we failrly busy. tomorrow we're booked solid. we close on the house tomorrow. i want one of these opened up. because tomorow we go live... it's a day full of promise. and often, that day arrives by train. big day today? even bigger one tomorrow. when csx trains move forward, so does the rest of the economy. csx. how tomorrow moves. i've got a nice long life ahead. big plans. so when i found out medicare doesn't pay all my medical expenses, i looked at my options. then i got a medicare supplement insurance plan. [ male announcer ] if you're eligible for medicare, you may know it only covers about 80% of your part b medical expenses. the rest is up to you. call now and find out about an aarp medicare supplement insurance plan, insured by unitedhealthcare insurance company. like all standardized medicare supplement insurance plans, it helps pick up some of what medicare doesn't pay. and could save you in out-of-pocke

friend reports now from london >> reporter: these charges are confirmed against one of black sew smith klein'seading executives are more serious than industry insiders anticipated. the maximum sentence for bribery is life. 10 years' jail is a more likely sentence if found guilty. >> gsk london headquarters said that it had no idea of what was allegedly taking place. chinese police say that travel agencies and consultancies were used to transfer bribes to doctors. >> in a statement, the company said: we take the allegations that have been made very seriously. they are deeply concerning to us and congtrary to the values of gsk. >> it, too, could face subsequent charges for corporate misbehavior. in video released by police to state television, one of the joint accused alleged that mr mr. riley sanctioned payments. >> translator: he once mentioned costs would be involved when building relations with the bay ying industry and commerce bureau. matt riley's response in that time was "go ahead." "the third accused told police >> translator: i feel very sorry and regretful for the damage caused to soc

they reportedly made inquiries to johnson & johnson, glaxo smith klein. >> an update from the chief internationalspondent michelle caruso-cabrera. >> a very controversial election. let's start with ukraine. referendums over the weekend. it happened yesterday. chaotic by all definitions according to reporters who were on the ground. the fast overwhelming majority of people voted for greater autonomy from kiev. this is all a side show. what we want to see is see what vladimir putin does in response to violence that did happen over the weekend. ukrainian national guardsmen opened fire on some individuals. conflicting reports. russian agencies say at least one dead. the russian market rallied dramatically on thursday. that's the last name we heard from flat mere putin. he took a much softer tone about ukraine. pretty much holding on to the big gains we saw thursday and friday. let's get to india's markets as well. the two marriage indexes at all time record highs. it is expected when we get the exit polls in an hour and a half -- no. polls close 8:30. in india, 6:00 p.m. there. a half hour later, we

. >> it used to be smith klein and then there was a beckham, a glaxo smithkline. i think some were cross borders. i don't remember thinkingen some was trying to lower their tax rate at the time. this is a new twist. >> this characterized the discussions this morning in the uk. this panel really given ian read, the ceo of pfizer, a tough time here. just as i left it, they were talking about taxes and the tax rate in the uk and whether this was driven primarily by that tax idea. >> he said l says no. >> he says there are other considerations like r&d and the pipeline. they were challenging him on the commitments they were making to the uk and potentially cutting that r&d spend there. we have a clip of him talking about keeping some of the r&d force in the uk. >> we've made a commitment to include, globally, i say globally we'd probably reduce the combined budget. i haven't said in which countries and where we reduce that. a lot of programs are duplicated. what i have said is 20% of our global r & d head count will be in the uk. has any other company made that promis